Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

617
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
617
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

2.7K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

788
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
788
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

563
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
563

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted use of Prostaglandin E1 Therapy in "Duct-dependent" Congenital Diaphragmatic Hernia.

American journal of respiratory and critical care medicine·2026
Same author

Structured Online Support to Inform and Assist Antidepressant Deprescribing in Primary Care: Protocol for a Pragmatic, Randomized Controlled Trial (The WiserAD Trial).

JMIR research protocols·2026
Same author

Development of a novel split, frozen, thawed and washed red cell component for intrauterine transfusion.

Vox sanguinis·2026
Same author

Early left ventricular diastolic function and disease severity in congenital diaphragmatic hernia.

Pediatric research·2025
Same author

Serotonin reuptake inhibiting antidepressants: A trigger for visual snow syndrome?

The International journal of risk & safety in medicine·2025
Same author

Drug safety: The roles of big data and clinical experience.

Indian journal of medical ethics·2025

Related Experiment Video

Updated: Apr 28, 2026

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

7.4K

Sudden cardiac death & the Reverse Dodo Verdict.

David Healy1, Gareth Howe1, Derelie Mangin2

  • 1North Wales Department of Psychological Medicine, Bangor, Wales, UK.

The International Journal of Risk & Safety in Medicine
|June 7, 2014
PubMed
Summary

Adverse drug effects on cardiac QT intervals are a serious, underrecognized cause of sudden cardiac death. This paper proposes novel methods to address this significant mortality risk in the era of polypharmacy.

Keywords:
QT intervalsadverse event databasesantidepressantsantipsychoticscardiac appspolypharmacyreverse dodo verdict

More Related Videos

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

868
A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

770

Related Experiment Videos

Last Updated: Apr 28, 2026

Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

7.4K
Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

868
A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

770

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Adverse effects on cardiac QT intervals have been known for 50 years, linked to sudden death but poorly recognized.
  • Regulatory actions 20 years ago highlighted treatment-related cardiac effects and their contribution to sudden cardiac deaths.
  • In the current polypharmacy environment, unanticipated cardiac effects are increasingly common and a significant cause of mortality.

Purpose of the Study:

  • To address the underreporting and underdiagnosis of treatment-related adverse cardiac events.
  • To propose novel methods for managing the risks associated with QT interval prolongation.
  • To improve recognition and reduce mortality from drug-induced cardiac side effects.

Main Methods:

  • The paper proposes two novel methods for handling adverse effects on cardiac QT intervals.
  • Methodology focuses on improving the recognition of these events, which often requires timely electrocardiograms (ECGs).
  • The proposed methods aim to mitigate the risks in an era of polypharmacy and drug interactions.

Main Results:

  • The study identifies a significant and underrecognized mortality risk from drug-induced QT interval prolongation.
  • Evidence suggests underreporting and underdiagnosis due to the need for timely ECG monitoring.
  • The proposed methods are designed to tackle these challenges in clinical practice.

Conclusions:

  • Treatment-related QT interval prolongation remains a critical and underappreciated cause of sudden cardiac death.
  • The complexity of polypharmacy exacerbates the risk of unanticipated cardiac effects.
  • Implementing the proposed methods is crucial for improving patient safety and reducing mortality.